Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy

AIDS

Volumn 16, Issue 13, 2002, Pages 1835-1837

  Gross, Robert ^a   Bilker, Warren B ^a   Friedman, Harvey M ^a   Coyne, James C ^a   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACCURACY; ARTICLE; CLINICAL ARTICLE; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NURSE PRACTITIONERS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PHYSICIANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0037032058     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200209060-00021     Document Type: Article

References (11)

1. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society - USA Panel. JAMA 2000, 283:381-390.
2. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000, 14:357-366.
3. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000, 133:21-30.
4. Hirsch MS, Conway B, D'Aquila RT, et al. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society - USA Panel. JAMA 1998, 279:1984-1991.
5. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998, 279:1977-1983.
6. Sollitto S, Mehlman M, Youngner S, Lederman MM. Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment? AIDS 2001, 15:153-159.
7. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol 1997, 50:385-391.
8. Bogart LM, Catz SL, Kelly JA, Benotsch EG. Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making 2001, 21:28-36.
9. Bogart LM, Kelly JA, Catz SL, Sosman JM. Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquired Immune Defic Syndr 2000, 23:396-404.
10. Gross R, Bilker W, Friedman H, Strom B. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 2001, 15:2109-2117.
11. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.